Retroperitoneal soft tissue sarcomas - Patterns of recurrence in 167 patients treated at a single institution

被引:146
|
作者
Gronchi, A
Casali, PG
Fiore, M
Mariani, L
Lo Vullo, S
Bertulli, R
Colecchia, M
Lozza, L
Olmi, P
Santinami, M
Rosai, J
机构
[1] Ist Nazl Studio & Cura Tumori, Dept Surg, I-20133 Milan, Italy
[2] Ist Nazl Studio & Cura Tumori, Dept Biostat, I-20133 Milan, Italy
[3] Ist Nazl Studio & Cura Tumori, Dept Radiat Oncol, I-20133 Milan, Italy
[4] Ist Nazl Studio & Cura Tumori, Dept Pathol, I-20133 Milan, Italy
关键词
sarcoma; retroperitoneal tumors; prognosis; histotype; pattern of failure;
D O I
10.1002/cncr.20269
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to assess long-term prognosis and patterns of failure in patients with retroperitoneal soft tissue sarcoma who underwent surgery with curative intent at a single institution. Several series of patients with retroperitoneal sarcoma were reported, providing widely variable data regarding local and distant failure. METHODS. Overall, 167 consecutive patients who underwent surgery for retroperitoneal soft tissue sarcoma over a 20 year span at a single referral center were reviewed retrospectively. Eighty-two patients presented with primary disease, whereas 85 patients had recurrent locoregional tumors. Surgical resection was considered macroscopically complete in 147 of 167 patients (88%). RESULTS. overall survival at 10 years after definitive surgery was approximately 27%, and the disease-free survival was approximately 16%. Only a minority of patients developed distant metastases. The risk of recurrence was correlated with whether patients underwent surgery for primary disease or for recurrent disease; the 10 year disease-free survival rate was 27% in the former group and 4.6% in the latter group. Histotype and malignancy grade were other prognostic factors, with the former found to be predictive of the pattern of failure and the latter predictive of overall survival. CONCLUSIONS. Local recurrence after primary surgery and high-grade malignancy were associated with the worst Survival. Histologic subtype appeared to influence the pattern of recurrence, which mainly was local for patients with liposarcoma but was both local and distant for patients with the other histotypes. (C) 2004 American Cancer Society.
引用
收藏
页码:2448 / 2455
页数:8
相关论文
共 50 条
  • [41] Primary adult soft tissue sarcomas: analysis of 294 patients
    Necati Alkis
    Sadık Muallaoğlu
    Murat Koçer
    Ülkü Yalçıntaş Arslan
    Ayşe Gök Durnalı
    Saadet Tokluoğlu
    Gökhan Çelenkoğlu
    Fatma Paksoy
    Ugur Coskun
    Medical Oncology, 2011, 28 : 391 - 396
  • [42] Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas
    Braemswig, Kira
    Ploner, Ferdinand
    Martel, Alexandra
    Bauernhofer, Thomas
    Hilbe, Wolfgang
    Kuehr, Thomas
    Leitgeb, Clemens
    Mlineritsch, Brigitte
    Petzer, Andreas
    Seebacher, Veronika
    Stoeger, Herbert
    Girschikofsky, Michael
    Hochreiner, Gerhard
    Ressler, Sigrun
    Romeder, Franz
    Woell, Ewald
    Brodowicz, Thomas
    ANTI-CANCER DRUGS, 2014, 25 (07) : 848 - 853
  • [43] Prognostic factors in soft tissue sarcomas: a study of 395 patients
    Stefanovski, PD
    Bidoli, E
    De Paoli, A
    Buonadonna, A
    Boz, G
    Libra, M
    Morassut, S
    Rossi, C
    Carbone, A
    Frustaci, S
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (02): : 153 - 164
  • [44] THE RELATIONSHIP BETWEEN LOCAL RECURRENCE AND RADIOTHERAPY TREATMENT VOLUME FOR SOFT TISSUE SARCOMAS TREATED WITH EXTERNAL BEAM RADIOTHERAPYAND FUNCTION PRESERVATION SURGERY
    Dickie, Colleen I.
    Griffin, Anthony M.
    Parent, Amy L.
    Chung, Peter W. M.
    Catton, Charles N.
    Svensson, Jon
    Ferguson, Peter C.
    Wunder, Jay S.
    Bell, Robert S.
    Sharpe, Michael B.
    O'Sullivan, Brian
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : 1528 - 1534
  • [45] Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma
    Spolverato, Gaya
    Callegaro, Dario
    Gronchi, Alessandro
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (07)
  • [46] Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma
    Gaya Spolverato
    Dario Callegaro
    Alessandro Gronchi
    Current Treatment Options in Oncology, 2020, 21
  • [47] Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas
    Zhang, Qing
    Yang, Yongkun
    You, Xia
    Ju, Yongzhi
    Zhang, Qin
    Sun, Tingting
    Liu, Weifeng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] Management of elderly patients with bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group
    Tanaka, Kazuhiro
    Ozaki, Toshifumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (06) : 526 - 530
  • [49] Fatigue Syndrome in Patients with Bone and Soft Tissue Sarcomas: An Observational Study
    Morri, Mattia
    Boccomino, Riccardo
    Brruku, Eugenio
    Terra, Ausilia Bellina
    Boschi, Rita
    Raucci, Giovanni
    Sabbi, Daniela
    Ibrahim, Toni
    Coluccino, Paola
    SEMINARS IN ONCOLOGY NURSING, 2025, 41 (01)
  • [50] Cerebellar, Pancreatic, and Paraspinal Metastases in Soft Tissue Sarcomas: Unusual Sites or Changing Patterns?
    Bedre, Girish
    Gupta, Tejpal
    Rajasekharan, Preetha
    Munshi, Anusheel
    Jalali, Rakesh
    JOURNAL OF THE PANCREAS, 2007, 8 (04): : 444 - 449